PubRank

G Passalacqua

Author PubWeight™ 132.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008 12.35
2 Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2011 2.51
3 Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012 2.17
4 Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy 2006 1.84
5 Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007 1.75
6 Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000 1.50
7 Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers. Clin Exp Allergy 2001 1.50
8 Allergic rhinitis in the Italian population evaluated through the national database of general practitioners. Allergy 2007 1.48
9 The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009 1.34
10 Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003 1.34
11 GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy 2010 1.28
12 Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy 2010 1.24
13 Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy 2008 1.20
14 Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy 2012 1.13
15 Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003 1.13
16 Systemic reactions from skin testing: literature review. J Investig Allergol Clin Immunol 2006 1.06
17 Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995 1.05
18 Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy 2006 1.05
19 Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004 1.04
20 The classification of allergic rhinitis and its cytological correlate. Allergy 2011 1.00
21 Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions. J Investig Allergol Clin Immunol 2004 1.00
22 Seasonal and perennial allergic rhinitis: is this classification adherent to real life? Allergy 2005 0.98
23 Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005 0.96
24 Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol 2012 0.96
25 Effects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST study. Eur J Phys Rehabil Med 2014 0.95
26 How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy 2011 0.95
27 The nocebo effect during oral challenge in subjects with adverse drug reactions. Eur Ann Allergy Clin Immunol 2008 0.94
28 The safety of sublingual immunotherapy with one or multiple pollen allergens in children. Allergy 2008 0.94
29 Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Allergy 2005 0.94
30 Evidence of desloratadine syrup efficacy and tolerability in children with pollen-induced allergic rhinitis. Allergy 2005 0.93
31 In vitro and in vivo biological activities of old and fresh Cupressus arizonica pollen. J Investig Allergol Clin Immunol 2006 0.93
32 European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'. Allergy 2011 0.92
33 How much specific is the association between hymenoptera venom allergy and mastocytosis? Allergy 2009 0.91
34 Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999 0.90
35 CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children. Allergy 2005 0.90
36 Allergic reactions to honey and royal jelly and their relationship with sensitization to compositae. Allergol Immunopathol (Madr) 1999 0.90
37 Correlation among FEV, nitric oxide and asthma control test in newly diagnosed asthma. Allergy 2007 0.90
38 Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy 2006 0.89
39 Anaphylaxis to sesame. Allergy 2000 0.88
40 Is sensitization to furry animals an independent allergic phenotype in nonoccupationally exposed individuals? J Investig Allergol Clin Immunol 2011 0.88
41 Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study. Allergy 2001 0.88
42 Administration regimens for sublingual immunotherapy to pollen allergens: what do we know? Allergy 2009 0.87
43 Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy. Allergy 1999 0.87
44 Continuous versus on demand treatment with cetirizine for allergic rhinitis. Ann Allergy Asthma Immunol 1997 0.86
45 Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon. Respir Med 2007 0.86
46 Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena. Am J Respir Crit Care Med 1994 0.86
47 Does a 'reverse' atopic march exist? Allergy 2008 0.86
48 Fibrous invasive (Riedel's) thyroiditis with critical response to steroid treatment. J Endocrinol Invest 1995 0.86
49 Allergen-specific immunoglobulin E in the skin and nasal mucosa of symptomatic and asymptomatic children sensitized to aeroallergens. J Investig Allergol Clin Immunol 2010 0.85
50 Evaluation of the IgE cross-reactions among vespid venoms. A possible approach for the choice of immunotherapy. Allergy 2007 0.85
51 A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. Clin Exp Allergy 2009 0.85
52 Unconventional medicine: a risk of undertreatment of allergic patients. Allergy 1999 0.85
53 Nasal cytology: the "infectious spot", an expression of a morphological-chromatic biofilm. Eur J Clin Microbiol Infect Dis 2011 0.84
54 Underdiagnosis and undertreatment of asthma: a 9-year study of Italian conscripts. Int Arch Allergy Immunol 2001 0.84
55 Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy 2006 0.84
56 Sensitization profiles in polysensitized patients from a restricted geographical area: further lessons from multiplexed component resolved diagnosis. Eur Ann Allergy Clin Immunol 2011 0.84
57 Severe respiratory allergy induced by indirect exposure to rabbit dander: a case report. Allergy 2004 0.84
58 Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy 2006 0.84
59 Seasonal rhinitis and azelastine: long- or short-term treatment? J Allergy Clin Immunol 1997 0.83
60 Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience. J Investig Allergol Clin Immunol 1997 0.83
61 Localized eosinophilic ileitis with mastocytosis successfully treated with oral budesonide. Allergy 2007 0.83
62 Effects of H1 antihistamines on adhesion molecules: a possible rationale for long-term treatment. Clin Exp Allergy 1999 0.83
63 Airborne pollens and prevalence of pollenosis in western Liguria: a 10-year study. J Investig Allergol Clin Immunol 1999 0.83
64 Looking for immunotolerance: a case of allergy to baker's yeast (Saccharomyces cerevisiae). Eur Ann Allergy Clin Immunol 2005 0.83
65 Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach. Allergy 2013 0.83
66 Specific immunotherapy among Italian specialists. Allergy 2006 0.83
67 Asthma treatment: 'magic bullets which seek their own targets'. Allergy 2007 0.83
68 Nonsteroidal antiallergic treatments in allergic rhinitis. Am J Rhinol 2001 0.82
69 Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial. Allergy 1999 0.82
70 The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting. Allergy 2012 0.82
71 Systemic reactions to peach are associated with high levels of specific IgE to Pru p 3. Allergy 2009 0.82
72 Evaluation of food-pollen cross-reactivity by nose-mouth cross-challenge in pollinosis with oral allergy syndrome. Allergy 2005 0.82
73 A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exp Allergy 1994 0.82
74 Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 1997 0.82
75 Chronic urticaria and associated coeliac disease in children: a case-control study. Pediatr Allergy Immunol 2005 0.81
76 Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy. Ann Allergy Asthma Immunol 2001 0.81
77 Is hymenoptera venom allergy an occupational disease? Occup Environ Med 2008 0.81
78 Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis--a randomized controlled study. Eur Ann Allergy Clin Immunol 2005 0.81
79 The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. Allergy 2009 0.81
80 Local immunotherapy. Allergy 1998 0.81
81 Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. J Allergy Clin Immunol 1996 0.80
82 A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects. Clin Exp Allergy 2002 0.80
83 Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs. Drug Saf 1996 0.80
84 Beer-induced anaphylaxis due to barley sensitization: two case reports. J Investig Allergol Clin Immunol 1999 0.80
85 Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallenge. Int Arch Allergy Immunol 1998 0.80
86 The type of sensitizing allergen can affect the evolution of respiratory allergy. Allergy 2006 0.80
87 An adult case of eosinophilic pyloric stenosis maintained on remission with oral budesonide. Eur Ann Allergy Clin Immunol 2011 0.80
88 Factors influencing the prescription of allergen immunotherapy: the allergen immunotherapy decision analysis (AIDA) study. Eur Ann Allergy Clin Immunol 2013 0.79
89 Executive summary of European Task Force document on diagnostic tools in rhinology. Rhinology 2012 0.79
90 Pattern of use and diagnostic value of complementary/alternative tests for adverse reactions to food. Allergy 2005 0.79
91 Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity. Clin Exp Allergy 1997 0.79
92 Anaphylaxis due to lupine flour in a celiac patient. J Investig Allergol Clin Immunol 2007 0.79
93 Cold-induced rhinitis in skiers--clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. Am J Rhinol 2001 0.79
94 Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Allergy 2008 0.79
95 Aspirin challenge/desensitisation before coronary stenting in subjects with history of hypersensitivity. A pragmatic approach. Eur Ann Allergy Clin Immunol 2012 0.78
96 Sensitization to horse allergens in Italy: a multicentre study in urban atopic subjects without occupational exposure. Int Arch Allergy Immunol 2011 0.78
97 Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression. Clin Exp Allergy 1997 0.78
98 Allergy and the nose. Clin Exp Immunol 2008 0.78
99 Exercise-induced anaphylaxis to grape. Allergy 2001 0.78
100 Assessment of biofilm by nasal cytology in different forms of rhinitis and its functional correlations. Eur Ann Allergy Clin Immunol 2013 0.78
101 The biological potency of different extracts for sublingual immunotherapy assessed by skin prick tests. Eur Ann Allergy Clin Immunol 2010 0.78
102 The role of patient training in the management of seasonal rhinitis and asthma: clinical implications. Allergy 2001 0.78
103 Immunological treatments for occupational allergy. Int J Immunopathol Pharmacol 2013 0.78
104 Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge. Ann Allergy Asthma Immunol 2001 0.78
105 Cetirizine treatment of allergic cough in children with pollen allergy. Allergy 1997 0.78
106 Food-exercise-induced anaphylaxis in a boy successfully desensitized to cow milk. Allergy 2007 0.78
107 Cross reactivity between European hornet and yellow jacket venoms. Eur Ann Allergy Clin Immunol 2010 0.78
108 Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial. Allergy 2004 0.78
109 Safety and efficacy of immunotherapy with Polistes dominulus venom: results from a large Italian database. Allergy 2009 0.78
110 Allergy and skin diseases in musicians. Eur Ann Allergy Clin Immunol 2003 0.77
111 Severe skin reaction due to excipients of an oral iron treatment. Allergy 2007 0.77
112 The clinical efficacy of a sublingual monomeric allergoid at different maintenance doses: a randomized controlled trial. Int J Immunopathol Pharmacol 2010 0.77
113 Successful combined therapy for refractory chronic urticaria in a 10-year-old boy. Allergy 2004 0.77
114 Effect of statins on fibroblasts from human nasal polyps and turbinates. Eur Ann Allergy Clin Immunol 2008 0.77
115 Improvement of shrimp allergy after sublingual immunotherapy for house dust mites: a case report. Eur Ann Allergy Clin Immunol 2011 0.77
116 The safety of sublingual immunotherapy with one or more allergens in adults. Allergy 2008 0.77
117 Safety of celecoxib in patients with adverse reactions to nimesulide. Allergy 2005 0.77
118 Position paper: controversial and unproven diagnostic procedures for food allergy. Eur Ann Allergy Clin Immunol 2004 0.77
119 Tahini, a little known sesame-containing food, as an unexpected cause of severe allergic reaction. J Investig Allergol Clin Immunol 2006 0.77
120 General strategy for the management of bronchial asthma in pregnancy. Respir Med 2003 0.77
121 Comparison of ammoniated and nonammoniated extracts in children with latex allergy. Allergy 2003 0.77
122 Bronchial hyperresponsiveness in children with atopic rhinitis: a 7-year follow-up. Allergy 2004 0.76
123 Controlled study of preseasonal immunotherapy with grass pollen extract in tablets: effect on bronchial hyperreactivity. J Investig Allergol Clin Immunol 2001 0.76
124 Long-lasting clinical efficacy of allergen specific immunotherapy. Allergy 2002 0.76
125 Long-lasting effect of a monophosphoryl lipid-adjuvanted immunotherapy to parietaria. A controlled field study. Eur Ann Allergy Clin Immunol 2010 0.76
126 Relationship between degree of nonspecific hyperresponsiveness and number of positive skin tests in asthmatics. Monaldi Arch Chest Dis 2000 0.76
127 Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications. Allergy 2001 0.76
128 Cetirizine reduces conjunctival nonspecific hyperreactivity in children with mite allergy. J Investig Allergol Clin Immunol 1998 0.76
129 Anaphylaxis due to carrot as hidden food allergen. Allergol Immunopathol (Madr) 2002 0.76
130 Effectiveness of vacuum-cleaning in removing Fel d 1 allergen from cotton fabrics exposed to cats. Eur Ann Allergy Clin Immunol 2007 0.76
131 Euro coins and contact dermatitis. Allergy 2004 0.76
132 Rhinitis in pregnancy. Eur Ann Allergy Clin Immunol 2003 0.76
133 Reply to the letter by Dr Fleming Madsen (EAACI 'Standards for practical allergen-specific immunotherapy'). Allergy 2008 0.75
134 The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years. Respir Med 2001 0.75
135 True multifood allergy in a 4-year-old child: a case study. Allergol Immunopathol (Madr) 2002 0.75
136 Intranasal fluticasone propionate reduces ICAM-1 on nasal epithelial cells both during early and late phase after allergen challenge. Clin Exp Allergy 1998 0.75
137 Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. Clin Exp Allergy 2010 0.75
138 Randomized open comparison of montelukast and sublingual immunotherapy as add-on treatment in moderate persistent asthma due to birch pollen. J Investig Allergol Clin Immunol 2010 0.75
139 The perception of allergen-specific immunotherapy among Italian general practitioners. Eur Ann Allergy Clin Immunol 2012 0.75
140 Herbal medicine in COPD: tradition or revolution? Monaldi Arch Chest Dis 2003 0.75
141 Pharmacoeconomics of subcutaneous allergen immunotherapy. Eur Ann Allergy Clin Immunol 2007 0.75
142 Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1997 0.75
143 Molecular events in allergic inflammation: experimental models and possible modulation. Allergy 1997 0.75
144 When allergology meets psychiatry: delusional parasitosis (Ekbom's syndrome). Eur Ann Allergy Clin Immunol 2011 0.75
145 Role of leukotriene receptor antagonists in the management of mild-to-moderate asthma. Monaldi Arch Chest Dis 2001 0.75
146 Neuroradiol J 2013 0.75
147 Anaphylaxis due to Brazil nut skin testing in a walnut-allergic subject. J Investig Allergol Clin Immunol 2005 0.75
148 Comparative study between two immunoassays for detection of allergen-specific IgG4. J Investig Allergol Clin Immunol 1991 0.75
149 Melkersson-Rosenthal syndrome associated with parvovirus B19 viraemia and haemophagocytic lymphohistiocytosis. Clin Exp Dermatol 2009 0.75
150 [Role of polychemoembolization in the treatment of primary and secondary tumors of the liver]. Clin Ter 1995 0.75
151 Is alternative medicine acceptable in allergology? Allergy 2000 0.75
152 Angioedema after administration of methylprednisolone to treat drug allergy. Allergy 2007 0.75
153 Delayed selective reaction to clavulanic acid: a case report. J Investig Allergol Clin Immunol 2005 0.75
154 Pollen, mite and mould samplings by a personal collector at high altitude in Nepal. J Investig Allergol Clin Immunol 1998 0.75
155 Sublingual IT in OAS. Allergy 2000 0.75
156 The role of health technology assessment in the comprehensive evaluation of the impact of immunotherapy on real practice. Eur Ann Allergy Clin Immunol 2007 0.75
157 Epidural hematoma caused by a spinal osseous epidural arteriovenous fistula in a 14-year-old patient. A case report. Neuroradiol J 2009 0.75
158 Measurement of nasal IgE in an epidemiological study: assessment of its diagnostic value in respiratory allergy. Eur Ann Allergy Clin Immunol 2004 0.75
159 Direct and prolonged exposure to dogs does not influence the degree of skin prick test positivity to dog allergen. J Investig Allergol Clin Immunol 2005 0.75
160 Immunologic and clinical evaluation of a 12-month course of specific immunotherapy. Ann Allergy 1989 0.75
161 Treatment with American Polistes venom was ineffective in an Italian patient allergic to European Polistes. Allergy 2007 0.75
162 Risk assessment of immediate systemic reactions from skin tests with β-lactam antibiotics. Int Arch Allergy Immunol 2011 0.75
163 IgG4: not only for allergists. Int J Immunopathol Pharmacol 2013 0.75
164 Pollen mixtures used as health food may be a harmful source of allergens. J Investig Allergol Clin Immunol 2001 0.75
165 Pizza, an unsuspected source of soybean allergen exposure. Allergy 1998 0.75
166 Effective long-term alpha-interferon treatment for hypereosinophilic syndrome. J Allergy Clin Immunol 1995 0.75
167 The role of nasal endoscopy in the prescription of allergen immunotherapy. Eur Ann Allergy Clin Immunol 2013 0.75
168 The effect of multiple allergens on histamine release in vivo assessed by skin prick test. Allergy 2008 0.75
169 Dermatological powder as hidden cause of occupational allergy due to casein: a case report. Occup Environ Med 2003 0.75
170 Developments in the field of allergy in 2012 through the eyes of Clinical & Experimental Allergy. Clin Exp Allergy 2013 0.75
171 Prevalence of allergy to Cypress. Allergy 2002 0.75
172 Aerobiological diagnosis of respiratory allergy by a personal sampler: two case reports. J Investig Allergol Clin Immunol 2003 0.75
173 [Hepatocellular carcinoma (HCC): the long-term response to tamoxifen. A clinical case report and review of the literature]. Minerva Med 1989 0.75
174 What do we need to learn to optimize the SLIT alternative? Eur Ann Allergy Clin Immunol 2006 0.75
175 Latex-jujube cross-reactivity: case report and immunological study. Allergy 2005 0.75
176 Antihistamines in atopic dermatitis. Allergy 1989 0.75
177 Antihistamines in the treatment of bronchial asthma. Present knowledge and future perspectives. Pulm Pharmacol Ther 2001 0.75
178 Two screening methods for detection of specific IgE to inhalant allergens. Comparison with skin prick test and RAST. J Investig Allergol Clin Immunol 1991 0.75
179 Survey on the safety of a no-updosing regimen of sublingual immunotherapy. Eur Ann Allergy Clin Immunol 2006 0.75
180 Aerobiologic diagnosis of brassicaceae-induced asthma. Allergy 2003 0.75
181 Sublingual or injection immunotherapy: the final answer? Allergy 2004 0.75
182 Continuing medical education. The point of view of asthmatic patients at the beginning of a mandatory CME system. J Investig Allergol Clin Immunol 2004 0.75
183 Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA. J Nutr Health Aging 2017 0.75
184 Economic evaluation of sublingual immunotherapy: an analysis of literature. Eur Ann Allergy Clin Immunol 2007 0.75
185 Skin reactions to clonidine: not just a local problem. Case report. Allergol Immunopathol (Madr) 2000 0.75
186 Azelastine eye drops reduce conjunctival hyperresponsiveness to hyperosmolar glucose challenge in children with asymptomatic mite conjunctivitis. J Investig Allergol Clin Immunol 1999 0.75
187 Severe systemic reactions caused by poppy seed. J Investig Allergol Clin Immunol 1999 0.75
188 Sport, immune system and respiratory infections. Eur Ann Allergy Clin Immunol 2003 0.75
189 A multi-allergen ELISA screening method. Comparison with Pharmacia CAP system and Phazet skin prick test. Allergol Immunopathol (Madr) 1993 0.75
190 Prevalence of latex-specific IgE in blood donors: an Italian survey. Allergy 1999 0.75